Skip to main content
Canntab Therapeutics Limited logo

Canntab Therapeutics Limited — Investor Relations & Filings

Ticker · CTABF LEI · 529900979I76WYMMKK84 CSE Manufacturing
Filings indexed 76 across all filing types
Latest filing 2021-04-29 Regulatory Filings
Country CA Canada
Listing CSE CTABF

About Canntab Therapeutics Limited

https://canntab.ca/

Canntab Therapeutics Limited is a phytopharmaceutical company specializing in the research, development, and manufacturing of advanced pharmaceutical grade cannabis formulations. The company focuses on innovative solid oral dosage delivery methods, positioning itself as a leader in this medical segment. Its product portfolio includes patented Instant Release (IR) and Extended Release (XR) tablets containing precise doses of THC, CBD, and other Cannabinoids. These formulations are designed to offer medical simplicity and enhanced dosage control for individuals seeking health and wellness solutions.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2021-04-29 English
Interim MD&A - English.pdf
Regulatory Filings
2021-04-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2021-04-29 English
News release - English.pdf
Regulatory Filings
2021-03-30 English
Material change report - English.pdf
Regulatory Filings
2021-03-12 English
News release - English.pdf
Regulatory Filings
2021-03-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.